Microdosing midazolam in children: age-related changes in absorption of oral drugs

Mise à jour : Il y a 4 ans
Référence : EUCTR2014-003269-46

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

To describe the total apparent CYP3A mediated clearance (Cl/F) of midazolam in the paediatric intensive care population from the age of 0 to 6 years, as surrogate marker of intestinal and hepatic CYP3A activity.


Critère d'inclusion

  • Age-related changes in drug absorption and metabolism in children

Liens